Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

57.67
Delayed Data
As of Feb 09
 +0.74 / +1.30%
Today’s Change
54.17
Today|||52-Week Range
72.31
-12.14%
Year-to-Date

Today’s Trading

Previous close56.93
Today’s open56.46
Day’s range56.40 - 58.19
Volume6,171,861
Average volume (3 months)5,824,403
Market cap$58.1B
Dividend yield2.37%
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+139.61%
Earnings growth (this year)+6.87%
Earnings growth (next 5 years)+5.44%
Revenue growth (last year)-0.47%
P/E ratio27.9
Price/Sales2.43
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-3.86-12.25%
DEPODepomed Inc+0.59+3.88%
DNAIProNAi Therapeutics ...+0.04+0.60%
OASMOasmia Pharmaceutica...+0.29+7.29%
Data as of 02/09/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)$1.29
Annual revenue (last year)$20.3B
Annual profit (last year)$3.1B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers